Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-01-12T11:37:09.058Z Has data issue: false hasContentIssue false
  • English
  • Français

A systematic review on delayed acquisition of post-gadolinium magnetic resonance imaging in Ménière's disease: imaging of the endolymphatic spaces

Published online by Cambridge University Press:  08 June 2022

A Han  and
G Kontorinis Open the ORCID record for G Kontorinis [Opens in a new window]
A Han
Affiliation:
Medical School University of Glasgow, Glasgow, Scotland, UK
G Kontorinis*
Affiliation:
Medical School University of Glasgow, Glasgow, Scotland, UK Department of Otorhinolaryngology, Head and Neck Surgery, Queen Elizabeth University Hospital, Glasgow, Scotland, UK
*
Author for correspondence: Dr G Kontorinis, Department of Otorhinolaryngology, Head and Neck Surgery, Queen Elizabeth University Hospital, 1345 Govan Rd, Glasgow G51 4TF, Scotland, UK E-mail: [email protected] Fax: +44 141 347 8029
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

This study aimed to assess the clinical implications of delayed-acquisition post-gadolinium magnetic resonance imaging in identifying endolymphatic hydrops in Ménière's disease.

Method

This study was a systematic review using Medline and Embase and following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines with predetermined criteria, namely Ménière's disease, post-gadolinium magnetic resonance imaging and endolymphatic hydrops. The Quality Assessment of Diagnostic Accuracy Studies-2 tool was used to assess bias.

Results

Eleven studies were included; they all used 3T magnetic resonance imaging, with three-dimensional fluid-attenuated inversion recovery being the most common sequence. Intravenous gadolinium administration was more widely used compared with the intratympanic route. As for the timing of acquisition, 4 hours post-administration was universally used for the IV gadolinium and 24 hours was used for the intratympanic gadolinium. Despite patient-selection associated bias, all studies reported adequate visualisation of the endolymphatic spaces.

Conclusion

The use of delayed-acquisition magnetic resonance imaging is increasingly supported in visualising the endolymphatic spaces in Ménière's disease. Although the accessibility of 3T magnetic resonance imaging questions its wider applicability, it is a promising tool for the near future.

Keywords

Endolymphatic HydropsGadoliniumMeniere DiseaseMagnetic Resonance Imaging
Type
Review Article
Information
The Journal of Laryngology & Otology , Volume 137 , Issue 3 , March 2023 , pp. 239 - 245
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr G Kontorinis takes responsibility for the integrity of the content of the paper

References

Surgery, N, Monsell, M, Balkany, TA et al. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–5Google Scholar
Harris, JP, Alexander, TH. Current-day prevalence of Ménière's syndrome. Audiol Neurotol 2010;15:318–22CrossRefGoogle ScholarPubMed
Da Costa, SS, De Sousa, LCA, De Toledo Piza, MR. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am 2002;35:455–95CrossRefGoogle ScholarPubMed
Harcourt, J, Barraclough, K, Bronstein, AM. Meniere's disease. BMJ 2014;349:1–5CrossRefGoogle ScholarPubMed
Ghossaini, S, Miller, M. Meniere's disease. In: https://bestpractice.bmj.com/topics/en-gb/155?q=Meniere%27sdisease&c=recentlyviewed [25 April 2021]Google Scholar
Lingam, RK, Connor, SEJ, Casselman, JW, Beale, T. MRI in otology: applications in cholesteatoma and Ménière's disease. Clin Radiol 2018;73:35–4410.1016/j.crad.2017.09.002CrossRefGoogle ScholarPubMed
Niyazov, DM, Andrews, JC, Strelioff, D, Sinha, S, Lufkin, R. Diagnosis of endolymphatic hydrops in vivo with magnetic resonance imaging. Otol Neurotol 2001;22:813–17CrossRefGoogle ScholarPubMed
Fiorino, F, Pizzini, FB, Beltramello, A, Mattellini, B, Barbieri, F. Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Ménière's disease. Otol Neurotol 2011;32:472–7CrossRefGoogle ScholarPubMed
Carfrae, MJ, Holtzman, A, Eames, F, Parnes, SM, Lupinetti, A. 3 Tesla delayed contrast magnetic resonance imaging evaluation of Ménière's disease. Laryngoscope 2008;118:501–5CrossRefGoogle ScholarPubMed
Connor, SEJ, Pai, I. Endolymphatic hydrops magnetic resonance imaging in Ménière's disease. Clin Radiol 2021;76:e1–19CrossRefGoogle ScholarPubMed
Conte, G, Lo Russo, FM, Calloni, SF, Sina, C, Barozzi, S, Berardino, S et al. MR imaging of endolymphatic hydrops in Ménière's disease: not all that glitters is gold. Acta Otorhinolaryngol Ital 2018;38:369–76Google Scholar
Nakashima, T, Naganawa, S, Pyykkö, I, Gibson, WPR, Sone, M et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009;129:5–8CrossRefGoogle Scholar
Attyé, A, Eliezer, M, Boudiaf, N, Tropres, I, Chechin, D, Schmerber, S et al. MRI of endolymphatic hydrops in patients with Meniere's disease: a case-controlled study with a simplified classification based on saccular morphology. Eur Radiol 2017;27:3138–46CrossRefGoogle ScholarPubMed
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097CrossRefGoogle ScholarPubMed
Whiting, PF, Rutjes, AWS, Westwood, ME, Mallett, S, Reitsma, JB, Leeflang, MMG et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–3610.7326/0003-4819-155-8-201110180-00009CrossRefGoogle ScholarPubMed
Yoshida, T, Sugimoto, S, Teranishi, M, Otake, H, Yamazaki, M, Naganawa, S et al. Imaging of the endolymphatic space in patients with Ménière's disease. Auris Nasus Larynx 2018;45:33–8CrossRefGoogle ScholarPubMed
Baráth, K, Schuknecht, B, Monge Naldi, A, Schrepfer, T, Bockisch, CJ, Hegemann, SCA. Detection and grading of endolymphatic hydrops in Menière disease using MR imaging. Am J Neuroradiol 2014;35:1387–92CrossRefGoogle ScholarPubMed
Sepahdari, AR, Ishiyama, G, Vorasubin, N, Peng, KA, Linetsky, M, Ishiyama, A. Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere's disease: correlation of quantitative measures of endolymphatic hydrops with hearing. Clin Imaging 2015;39:26–3110.1016/j.clinimag.2014.09.014CrossRefGoogle ScholarPubMed
Tagaya, M, Yamazaki, M, Teranishi, M, Naganawa, S, Yoshida, T, Otake, H et al. Endolymphatic hydrops and blood-labyrinth barrier in Ménière's disease. Acta Otolaryngol 2011;131:474–910.3109/00016489.2010.534114CrossRefGoogle ScholarPubMed
Attyé, A, Eliezer, M, Medici, M, Tropres, I, Dumas, G, Krainik, A et al. In vivo imaging of saccular hydrops in humans reflects sensorineural hearing loss rather than Meniere's disease symptoms. Eur Radiol 2018;28:2916–22CrossRefGoogle ScholarPubMed
Claes, G, Van Den Hauwe, L, Wuyts, F, Van De Heyning, P. Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Menière's disease patients? Eur Arch Otorhinolaryngol 2012;269:413–18CrossRefGoogle ScholarPubMed
Sano, R, Teranishi, M, Yamazaki, M, Isoda, H, Naganawa, S, Sone, M et al. Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol 2012;132:241–6CrossRefGoogle ScholarPubMed
Pakdaman, MN, Ishiyama, G, Ishiyama, A, Peng, KA, Kim, HJ, Pope, WB et al. Blood-labyrinth barrier permeability in menière disease and idiopathic sudden sensorineural hearing loss: findings on delayed postcontrast 3D-FLAIR MRI. Am J Neuroradiol 2016;37:1903–8CrossRefGoogle ScholarPubMed
Shi, H, Li, Y, Yin, S, Zou, J. The predominant vestibular uptake of gadolinium through the oval window pathway is compromised by endolymphatic hydrops in Meniere's disease. Otol Neurotol 2014;35:315–22CrossRefGoogle ScholarPubMed
Naganawa, S, Yamazaki, M, Kawai, H, Bokara, K, Iida, T, Sone, M et al. MR imaging of Meniere's disease after combined intratympanic and intravenous injection of gadolinium using HYDROPS2. Magn Reson Med Sci 2014;13:133–710.2463/mrms.2013-0061CrossRefGoogle ScholarPubMed